Navidea Biopharma 8-K Shows Co. Received NYSE American Notice Related To Non Compliance With $2M Minimum Shareholder Equity Requirement; Co. Has Until Apr. 15, 2019 To Be Considered For Continued Trading
Benzinga Newsdesk